OPKO HEALTH, INC.
OPKO HEALTH, INC.
Insider Sentiment (TTM):
Last Purchase:2026-03-20Last Sale:-Shares Purchased (TTM):2,433,300Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:198,409,071Shares Outstanding:758,876,415Institutional Ownership Pct.:26.15%
Earnings Market Reaction:
Filing Date:2026-07-27Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | - | - | - | - | - | - | - | - | 41 | 76 | 96 | 139 | |||||
Accounts Receivable Net Current | 82 | 80 | 90 | 95 | 99 | 96 | 118 | 107 | 105 | 111 | 123 | 117 | |||||
Inventory Net | 62 | 64 | 66 | 65 | 66 | 64 | 57 | 59 | 60 | 59 | 66 | 69 | |||||
Prepaid Expense And Other Assets Current | 56 | 49 | 57 | 52 | 59 | 54 | 55 | 57 | 32 | 25 | 25 | 32 | |||||
Assets Of Disposal Group Including Discontinued Op… | - | - | - | - | - | - | - | - | 120 | 120 | - | - | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | - | - | - | - | 87 | 87 | - | - | - | - | - | - | |||||
Assets Current | 500 | 535 | 582 | 627 | 583 | 738 | 662 | 630 | 358 | 391 | 309 | 357 | |||||
Property Plant And Equipment And Finance Lease Rig… | - | - | - | - | - | - | - | 72 | - | - | - | - | |||||
Property Plant And Equipment Net | 71 | 73 | 74 | 75 | 75 | 71 | 70 | - | 67 | 64 | 75 | 78 | |||||
Intangible Assets Net Excluding Goodwill | 478 | 496 | 516 | 535 | 556 | 569 | 617 | 641 | 659 | 680 | 740 | 758 | |||||
Goodwill | 482 | 482 | 484 | 484 | 484 | 477 | 529 | 536 | 530 | 531 | 598 | 594 | |||||
Long Term Investments | 40 | 11 | 14 | 13 | 13 | 13 | 55 | 101 | 101 | 41 | 16 | 19 | |||||
Operating Lease Right Of Use Asset | 44 | 46 | 47 | 46 | 47 | 48 | 54 | 63 | 62 | 63 | 68 | 45 | |||||
Other Assets Noncurrent | 19 | 19 | 19 | 20 | 20 | 19 | 19 | 19 | 8 | 9 | 9 | 9 | |||||
Assets | 1,829 | 1,857 | 1,932 | 1,996 | 1,973 | 2,128 | 2,200 | 2,256 | 1,980 | 1,974 | 2,012 | 2,057 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 50 | 44 | 41 | 51 | 57 | 59 | 47 | 63 | 82 | 71 | 70 | 67 | |||||
Accrued Liabilities Current | 78 | 83 | 84 | 96 | 91 | 113 | 118 | 123 | 95 | 89 | 90 | 92 | |||||
Operating Lease Liability Current | 11 | 11 | 11 | 10 | 10 | 10 | 13 | 13 | 12 | 12 | 13 | 11 | |||||
Convertible Notes Payable Current | - | - | 0 | 0 | 0 | 101 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Loans Payable To Bank Current | 11 | 10 | 10 | 13 | 14 | 12 | 15 | 13 | 22 | 23 | 27 | 30 | |||||
Liabilities Of Disposal Group Including Discontinu… | - | - | - | - | - | - | - | - | 9 | 10 | - | - | |||||
Liabilities Current | 149 | 148 | 147 | 169 | 171 | 296 | 193 | 212 | 220 | 204 | 200 | 201 | |||||
Operating Lease Liability Noncurrent | 34 | 36 | 37 | 36 | 37 | 38 | 49 | 52 | 50 | 51 | 54 | 35 | |||||
Convertible Long Term Notes Payable | 90 | 87 | 85 | 83 | 80 | 77 | 174 | 179 | 176 | 323 | 214 | 213 | |||||
Senior Long Term Notes | 247 | 247 | 246 | 246 | 246 | 246 | 246 | 245 | - | - | 0 | - | |||||
Deferred Income Tax Liabilities Net | 108 | 115 | 126 | 130 | 113 | 129 | 141 | 128 | 119 | 122 | 127 | 138 | |||||
Other Liabilities Noncurrent | 17 | 20 | 23 | 25 | 28 | 30 | 33 | 37 | 20 | 21 | 27 | 26 | |||||
Liabilities Noncurrent | 496 | 504 | 517 | 521 | 505 | 521 | 642 | 641 | 365 | 517 | 422 | 412 | |||||
Liabilities | 645 | 652 | 664 | 690 | 676 | 817 | 835 | 853 | 585 | 721 | 622 | 612 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | |||||
Treasury Stock Common Value | -2 | -2 | -3 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |||||
Additional Paid In Capital | 3,561 | 3,572 | 3,575 | 3,585 | 3,596 | 3,484 | 3,481 | 3,517 | 3,540 | 3,386 | 3,433 | 3,430 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -28 | -27 | -21 | -25 | -25 | -45 | -56 | -40 | -47 | -45 | -38 | -46 | |||||
Retained Earnings Accumulated Deficit | -2,354 | -2,346 | -2,291 | -2,259 | -2,281 | -2,133 | -2,065 | -2,079 | -2,104 | -2,094 | -2,012 | -1,945 | |||||
Stockholders Equity | 1,184 | 1,205 | 1,268 | 1,305 | 1,297 | 1,312 | 1,365 | 1,403 | 1,395 | 1,253 | 1,389 | 1,445 | |||||
Liabilities And Stockholders Equity | 1,829 | 1,857 | 1,932 | 1,996 | 1,973 | 2,128 | 2,200 | 2,256 | 1,980 | 1,974 | 2,012 | 2,057 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,000 | 1,250 | 1,000 | |||||
Common Stock Shares Issued | 776 | 785 | 790 | 799 | 810 | 701 | 701 | 712 | 727 | 727 | 782 | 782 | |||||
Treasury Stock Common Shares | 30 | 30 | 31 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 9 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.96% | 17.36% | -1.65% | - | - | - | - | - | - | - | - | - |
| 2025 | -6.67% | -4.44% | 0.00% | 10.16% | 13.28% | 18.75% | -7.69% | -8.39% | -10.49% | -6.67% | 3.33% | -8.33% |
| 2024 | 5.38% | -3.85% | 13.85% | 31.25% | 18.75% | 10.94% | 6.21% | 2.07% | 2.07% | -2.86% | -19.43% | -28.00% |
| 2023 | - | - | - | -6.49% | -12.43% | -30.27% | 14.18% | 12.69% | -26.87% | -3.03% | 24.24% | 33.33% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.35 | 3.61 | 3.97 | 3.70 | 3.41 | 2.49 | 3.43 | 2.97 | 1.63 | 1.91 | 1.55 | 1.78 | |||||
| Quick Ratio | 2.56 | 2.84 | 3.13 | 3.01 | 2.68 | 2.09 | 2.85 | 2.42 | 1.21 | 1.50 | 1.10 | 1.28 | |||||
| Working Capital | 350.87M | 386.98M | 435.20M | 457.81M | 412.15M | 441.75M | 468.99M | 417.98M | 138.43M | 186.97M | 109.42M | 156.69M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.54 | 0.54 | 0.52 | 0.53 | 0.52 | 0.62 | 0.61 | 0.61 | 0.42 | 0.58 | 0.45 | 0.42 | |||||
| Interest Coverage TTM | -1.07 | -0.97 | -1.08 | -1.01 | -1.24 | -2.67 | -3.20 | -5.12 | -11.74 | -11.12 | -11.63 | -8.94 | |||||
| Debt Ratio | 0.35 | 0.35 | 0.34 | 0.35 | 0.34 | 0.38 | 0.38 | 0.38 | 0.30 | 0.37 | 0.31 | 0.30 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.31 | 0.29 | 0.29 | 0.30 | 0.34 | 0.34 | 0.34 | 0.33 | 0.35 | 0.39 | 0.41 | 0.40 | |||||
| Days Sales Outstanding TTM | 56.27 | 55.21 | 62.63 | 57.18 | 56.26 | 54.93 | 61.78 | 57.47 | 80.58 | 53.15 | 52.98 | 50.66 | |||||
| Receivables Turnover TTM | 6.49 | 6.61 | 5.83 | 6.38 | 6.49 | 6.64 | 5.91 | 6.35 | 4.53 | 6.87 | 6.89 | 7.21 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.10 | -0.28 | -0.30 | -0.23 | -0.22 | -0.06 | -0.08 | -0.13 | -0.35 | - | - | -0.28 | |||||
| Free Cash Flow Per Share TTM | -0.18 | -0.23 | -0.25 | -0.27 | -0.33 | -0.31 | -0.30 | -0.29 | -0.12 | -0.08 | -0.06 | -0.05 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 40.77% | 35.98% | 33.93% | 35.29% | 32.65% | 31.78% | 30.64% | 14.60% | 18.98% | 29.60% | 36.84% | 49.27% | |||||
| Operating Profit Margin TTM | -8.21% | -17.42% | -19.35% | -17.48% | -22.00% | -21.43% | -21.32% | -26.42% | -37.21% | -24.75% | -18.18% | -16.52% | |||||
| Net Profit Margin TTM | -12.40% | -36.64% | -37.19% | -28.10% | -26.68% | -5.66% | -7.46% | -18.80% | -33.93% | -31.57% | -21.87% | -23.95% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -11.47% | -15.71% | -14.90% | -9.75% | -7.31% | -13.78% | -17.41% | -17.94% | -17.48% | -12.38% | -14.01% | -28.95% | |||||
| Net Income Growth (1Y) | -58.85% | 445.92% | 324.02% | 34.89% | -27.13% | -84.55% | -71.82% | -35.58% | 16.19% | -13.32% | -42.49% | -34.50% | |||||
| EPS Growth (1Y) | -57.07% | 383.12% | 291.78% | 20.57% | -35.53% | -83.74% | -69.47% | -30.31% | 25.27% | -7.85% | -44.99% | -34.60% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -15.54 | -4.06 | -4.19 | -6.68 | -5.87 | -28.58 | -19.17 | -7.74 | -3.59 | -3.36 | -6.01 | -5.79 | |||||
| P/B TTM | 0.96 | 0.72 | 0.75 | 0.92 | 0.80 | 0.85 | 0.75 | 0.74 | 0.62 | 0.68 | 0.82 | 0.83 | |||||
| P/S TTM | 1.93 | 1.49 | 1.56 | 1.88 | 1.57 | 1.62 | 1.43 | 1.45 | 1.22 | 1.06 | 1.31 | 1.39 | |||||
| Market Cap | 1.13B | 865.12M | 946.43M | 1.20B | 1.04B | 1.11B | 1.02B | 1.03B | 871.51M | 848.26M | 1.14B | 1.20B | |||||
| Enterprise Value | 1.22B | 952.50M | 1.03B | 1.29B | 1.12B | 1.29B | 1.19B | 1.21B | 1.01B | 1.10B | 1.25B | 1.28B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -134.02M | -174.22M | -190.82M | -212.06M | -259.29M | -206.24M | -208.50M | -199.99M | -86.07M | -58.80M | -44.47M | -41.11M | |||||
| Net Debt | 89.86M | 87.38M | 85.02M | 82.70M | 80.47M | 178.47M | 173.78M | 178.87M | 135.54M | 247.64M | 118.44M | 74.66M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2026-03-20Purchase
Owner: Paganelli, John A
Title: -
Shares: 10,000
Price/Share: $1.14
Value: $11,400.00
Shares Owned: 394,340
Relationship: Director
Ownership: Direct
2025-11-21Purchase
Owner: Frost, Gamma Investments …
Title: CEO & Chairman
Shares: 580,000
Price/Share: $1.32
Value: $765,600.00
Shares Owned: 216,706,448
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2025-11-20Purchase
Owner: Frost, Gamma Investments …
Title: CEO & Chairman
Shares: 580,000
Price/Share: $1.34
Value: $777,200.00
Shares Owned: 216,126,448
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2025-11-19Purchase
Owner: Frost, Gamma Investments …
Title: CEO & Chairman
Shares: 580,000
Price/Share: $1.30
Value: $754,000.00
Shares Owned: 215,546,448
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2025-11-18Purchase
Owner: Frost, Gamma Investments …
Title: CEO & Chairman
Shares: 533,300
Price/Share: $1.27
Value: $677,291.00
Shares Owned: 214,966,448
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
26.15%
Inst. Shares: 198,409,071
Shares Outstanding: 758,876,415
2025-12-31
26.17%
Inst. Shares: 196,534,272
Shares Outstanding: 751,132,891
2025-09-30
24.95%
Inst. Shares: 193,891,082
Shares Outstanding: 777,154,808
2025-06-30
25.54%
Inst. Shares: 201,227,909
Shares Outstanding: 788,006,992
2025-03-31
34.58%
Inst. Shares: 232,222,830
Shares Outstanding: 671,577,429
OPKO HEALTH, INC. (OPK) — SEC Financial Statements & Analysis
OPKO HEALTH, INC. (OPK) is a pharmaceutical preparations company, incorporated in DE. OPKO HEALTH, INC. trades on Nasdaq as: OPK. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), OPKO HEALTH, INC. reported a -11.47% year-over-year revenue growth, a Gross Profit Margin of 40.77% (TTM), a Debt-to-Equity ratio of 0.54x, a Price-to-Sales (P/S) ratio of 1.93x (TTM), a Price-to-Book (P/B) ratio of 0.96x (TTM), at a market cap of $1.13B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -11.47%
- Gross Profit Margin TTM
- 40.77%
- Debt To Equity
- 0.54x
- P/S TTM
- 1.93x
- P/B TTM
- 0.96x
- Market Cap
- $1.13B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is OPKO HEALTH, INC. in?
OPKO HEALTH, INC. (OPK) operates in the Pharmaceutical Preparations industry.
What is OPK's market cap?
OPKO HEALTH, INC. (OPK) has a market capitalization of $1.13B as of 2026-06-30.
What exchange does OPK trade on?
OPKO HEALTH, INC. (OPK) trades on the Nasdaq.
Where is OPKO HEALTH, INC. incorporated?
OPKO HEALTH, INC. is incorporated in DE.